Post by Unlearn.AI

💡 Most of what a single-arm trial can tell you is decided before it starts — in the design. In a new post, we look at how SOLA Biosciences is building AI-generated #digitaltwins into the design of SOL-257, its Phase 1/2 study of an investigational #ALS gene therapy, well before the first patient is enrolled. The aim: learn more from every participant in a trial with no control arm. https://lnkd.in/gRa68EF8